2-acetylaminofluorene has been researched along with nocodazole in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
| Brom, M; Cui, Y; Keppler, D; König, J; Nies, AT; Stöckel, B | 1 |
2 other study(ies) available for 2-acetylaminofluorene and nocodazole
| Article | Year |
|---|---|
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
Characterization of the 5'-flanking region of the human multidrug resistance protein 2 (MRP2) gene and its regulation in comparison withthe multidrug resistance protein 3 (MRP3) gene.
Topics: 2-Acetylaminofluorene; ATP-Binding Cassette Transporters; Base Sequence; Cloning, Molecular; DNA, Complementary; Fluorescent Antibody Technique, Indirect; Gene Expression Regulation; Genes, Reporter; Humans; Hydroxamic Acids; Immunoblotting; Mitochondrial Proteins; Molecular Sequence Data; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Nocodazole; Promoter Regions, Genetic; Ribosomal Proteins; RNA, Messenger; Saccharomyces cerevisiae Proteins; Transfection; Tumor Cells, Cultured | 2000 |